The FTSE Eurofirst 300 was down by over 1 percent to 1,466.97 on Tuesday. The banking sector was instrumental in the declines as worries about the US subprime mortgage sector continued in abundance, despite analyst opinion that it would not turn out to have that much effect in the European sector.

Among investment banks, UBS (SWX: UBSN; NYSE: UBS; TYO: 8657) dropped 1.1 percent to €70.20, while Deutsche Bank (NYSE: DB) and Credit Suisse (SWX: CSGN; NYSE: CS) each fell 1.9 percent, to €96.46 and €85.75 respectively. Commerzbank (DAX: CBK) was 2.9 percent lower, not only on the general sentiment in the sector, but also due to a statement from Citigroup (NYSE: C) that it is not interested in bidding on the German bank.

In the chemicals sector, Akzo Nobel (Eurofirst: AKZ; NAS: AKZOY) added 0.8 percent to €54.11, still buoyed by news of the sale of its Organon drugs unit to US company Schering-Plough (NYSE: SGP). ING (Euronext: INGA; NYSE: ING) upgraded Akzo from “hold” to “buy” and upped its target share price to €64, citing a sale price for the company that was €3 billion dollars than market estimates.

Altadis (IBEX-35: ALT) added 1 percent to €38.20 even though it denied that UK tobacco company Imperial Tobacco (LSE: IMT) was looking for a friendly merger in order to stop an approach by Kohlberg Kravis Roberts.

The FTSE Eurofirst 300 ended the day and the week higher on Friday, closing at 1,449.14. The Eurofirst added 0.1 percent on the session and 2 percent higher for the week.

In the pharmaceuticals sector, bids news sent both Schwarz Pharma of German and UCB of Belgium higher when the Schwarz family accepted a €4.4 billion offer, including both cash and shares, for the company in which they hold a 59.2 percent stake. Schwarz added 4.7 percent during the week to €95.99, while UCB was 9.2 percent highr to €52.25.

Bids news also brought gains to the tobacco sector after UK company Gallaher said it had received an offer which many think came from Japan Tobacco. Despite a decline on Friday after a downgrade from Cazenove, Gallaher was 24.2 percent higher over the week to £11.72. With investors hoping for more consolidation in the sector, French-Spanish tobacco group Altadis ended the week with a gain of 8.8 percent to €40.5.

Banks also had a good week. Irish banks were led higher by Anglo Irish Bank after it said that its pre-tax profits were better than had been expected and after UBS upped its target share price. Anglo Irish added 8.4 percent to €15.44, while Allied Irish Banks added 3.8 percent over the week to €21.49 even after it didn’t raise its growth guidance. Bank of Ireland, meanwhile, was 3.7 percent higher to €16.65.

Austrian banks also did well. Erste Bank added 4.2 percent to €57.78 after ING initiated coverage with a “buy” recommendation. Raiffeisen International was 6.8 percent higher to €99.90. Both banks do substantial business in eastern Europe.

New mergers and acquisitions rumors helped send the FTSE Eurofirst 300 higher on Thursday. The index added 0.5 percent to 1,447.86.

In the insurance sector, Swiss Life was 2.1 percent higher to SFr306 after it was rumored that Generali of Italy and Allianz of Germany might be ready to enter a bidding war over the Swiss insurer. Allianz was 0.7 percent higher to €149.61, while Generali, also a possible takeover target, gained 4 percent to €34.55.

French-Spanish tobacco group Altadis was up 7 percent to €40.37 after the confirmation of a bid for the UK company Gallaher raised hopes of more consolidation in the sector. JP Morgan commented that Altadis was a much more attractive target than Gallaher.

In the steel sector, ThyssenKrupp added 3.7 percent to €31.86 on positive broker comments. Deutsche Bank raised the steel maker’s target share price from €35 to €36, while West LB upped its target price from €32 to €34 and Commerzbank raised its earnings estimate for the 2006-2007 fiscal year by 16 percent.

Among telecommunications companies, Alcatel-Lucent gained 2.6 percent to €10.30 upon being added to Goldman Sachs’ “conviction buy” list. On the other hand, Dresdner Kleinwort retained its “sell” rating and target share price of €8, noting that Alcatel-Lucent isn’t a major manufacturer of mobile devices, unlike its rivals, Nokia and Ericsson.